4.7 Article

Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor

期刊

出版社

MDPI
DOI: 10.3390/ijms22189850

关键词

FSHR; biased signaling; allosteric ligands; system bias; operational model

资金

  1. French National Research Agency under the program Investissements d'avenir [LabEx MabImprove: ANR-10-LABX-53]
  2. Region Centre Val de Loire
  3. University of Modena and Reggio Emilia
  4. European Union
  5. European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant [665790]
  6. Japan Agency for Medical Research and Development (AMED) [PRIME 18gm5910013, LEAP 18gm0010004]
  7. Japan Society for the Promotion of Science (JSPS) [KAKENHI 17K08264]
  8. Biotechnology and Biological Sciences Research Council (BBSRC) [BB/S001565/1]
  9. Society for Endocrinology Early Career Grant
  10. INRAE
  11. BBSRC [BB/S001565/1] Funding Source: UKRI

向作者/读者索取更多资源

The study examined the pharmacological diversity of three benzamide and two thiazolidinone derivatives compared to FSH, discovering unique pharmacological efficacy and kinetic profiles for each ligand. The results show correlations between the kinetics of the ligands and CRE-dependent transcription, as well as clear system biases in cells depleted of Gαs or beta-arrestin genes.
Follicle-stimulating hormone receptor (FSHR) plays a key role in reproduction through the activation of multiple signaling pathways. Low molecular weight (LMW) ligands composed of biased agonist properties are highly valuable tools to decipher complex signaling mechanisms as they allow selective activation of discrete signaling cascades. However, available LMW FSHR ligands have not been fully characterized yet. In this context, we explored the pharmacological diversity of three benzamide and two thiazolidinone derivatives compared to FSH. Concentration/activity curves were generated for G alpha s, G alpha q, G alpha i, beta-arrestin 2 recruitment, and cAMP production, using BRET assays in living cells. ERK phosphorylation was analyzed by Western blotting, and CRE-dependent transcription was assessed using a luciferase reporter assay. All assays were done in either wild-type, G alpha s or beta-arrestin 1/2 CRISPR knockout HEK293 cells. Bias factors were calculated for each pair of read-outs by using the operational model. Our results show that each ligand presented a discrete pharmacological efficacy compared to FSH, ranging from super-agonist for beta-arrestin 2 recruitment to pure G alpha s bias. Interestingly, LMW ligands generated kinetic profiles distinct from FSH (i.e., faster, slower or transient, depending on the ligand) and correlated with CRE-dependent transcription. In addition, clear system biases were observed in cells depleted of either G alpha s or beta-arrestin genes. Such LMW properties are useful pharmacological tools to better dissect the multiple signaling pathways activated by FSHR and assess their relative contributions at the cellular and physio-pathological levels.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据